Jorun Rugkåsa, PhD, Health Services Research Unit, Akershus University Hospital, Norway, and Department of Psychiatry, University of Oxford, UK; John Dawson, LLD, Faculty of Law, University of Otago, Dunedin, New Zealand.
Br J Psychiatry. 2013 Dec;203(6):406-8. doi: 10.1192/bjp.bp.113.133900.
Community treatment orders (CTOs) have been widely introduced to address the problems faced by 'revolving door' patients. A number of case-control studies have been conducted but show conflicting results concerning the effectiveness of CTOs. The Oxford Community Treatment Order Evaluation Trial (OCTET) is the third randomised controlled trial (RCT) to show that CTOs do not reduce rates of readmission over 12 months, despite restricting patients' autonomy. This evidence gives pause for thought about current CTO practice. Further high-quality RCTs may settle the contentious debate about effectiveness.
社区治疗令(CTO)已被广泛引入,以解决“循环门”患者所面临的问题。已经进行了一些病例对照研究,但关于 CTO 的效果却显示出相互矛盾的结果。牛津社区治疗令评估试验(OCTET)是第三个随机对照试验(RCT),表明尽管限制了患者的自主权,但 CTO 并不能降低 12 个月内的再入院率。这一证据让人们对当前的 CTO 实践产生了反思。进一步的高质量 RCT 可能会解决关于有效性的有争议的辩论。